Home › Funds › Kynam Capital Management, LP › INSM
Kynam Capital Management, LP position in INSM
INSMED INC · Health Care
Kynam Capital Management, LP reported holding 100,000 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 0.59% of its reported portfolio and ranking #22 among its reported holdings. Kynam Capital Management, LP has disclosed INSM holdings in 2 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kynam Capital Management, LP's INSM position evolved
Kynam Capital Management, LP first disclosed a stake in INSM in Q2 2024 at 1,000,000 shares (US$67.0M). Across 2 filings, Kynam Capital Management, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 100,000 shares valued at US$10.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 1.00M | $67.00M | New |
| Q2 2026 | 100.00K | $10.66M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INSM and 13F data
INSM (INSMED INC) is a Health Care company. 40 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INSM
- BAKER BROS. ADVISORS LP 8.80M sh · $937.84M · Q2 2026
- Darwin Global Management, Ltd. 6.43M sh · $673.60M · Q2 2026
- Orbis Allan Gray Ltd 6.08M sh · $647.88M · Q2 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- Artisan Partners Limited Partnership 5.44M sh · $580.20M · Q2 2026
- RTW INVESTMENTS, LP 4.84M sh · $516.35M · Q2 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- MAVERICK CAPITAL LTD 2.15M sh · $229.31M · Q2 2026
- Qube Research & Technologies Ltd 1.68M sh · $179.37M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.63M sh · $173.74M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $170.59M · Q2 2026
- Bellevue Group AG 1.39M sh · $148.57M · Q2 2026
More on Kynam Capital Management, LP
FAQ
How long has Kynam Capital Management, LP held INSM?
Kynam Capital Management, LP has disclosed INSM holdings in 2 of the last 9 reported quarters, going back to Q2 2024.
What is Kynam Capital Management, LP's current position in INSM?
As of Q2 2026, Kynam Capital Management, LP holds 100.00K shares of INSM (INSMED INC), valued at $10.66M, representing 0.59% of its reported portfolio and ranking #22.
Has Kynam Capital Management, LP been buying or selling INSM?
In the latest 13F filing (Q2 2026), Kynam Capital Management, LP newly opened its position in INSM.
Which other funds hold INSM?
Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.